세계의 디지털 바이오마커 시장 규모, 점유율, 성장 분석 : 유형별, 임상 실천별, 치료 영역별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Digital Biomarkers Market Size, Share, and Growth Analysis, By Type, By Clinical Practice, By Therapeutic Area, By End Users, By Region - Industry Forecast 2025-2032
상품코드:1701040
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 04월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
디지털 바이오마커 세계 시장 규모는 2023년 39억 달러, 2024년 50억 2,000만 달러에서 2032년에는 380억 5,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 28.8%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
디지털 바이오마커 시장은 헬스케어 기술의 급속한 발전과 의료비 증가, 그리고 원격 간호 서비스 및 원격 환자 모니터링에 대한 수요 증가로 인해 강력한 성장세를 보이고 있습니다. 이 시장을 이끄는 주요 요인으로는 분산형 임상시험에 대한 투자 확대, 치료 용도의 확대, 스마트폰 보급에 따른 웨어러블 기기의 급증 등을 들 수 있습니다. 호흡, 음성, 체온, 안구 운동 등 바이탈 지표를 감지할 수 있는 혁신적인 기술로 복잡한 질환의 실시간 모니터링이 가능해졌습니다. 특히 음성을 통한 디지털 바이오마커는 큰 성장 기회를 가지고 있습니다. 룩셈부르크 보건 연구소의 CoLive Voice와 같은 이니셔티브는 원격 위험 평가 및 질병 관리의 잠재력을 강조하고 있습니다. 스마트워치와 피트니스 트래커를 사용하는 소비자가 증가함에 따라 시장은 지속적으로 확대될 준비가 되어 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술 분석
디지털 바이오마커 시장 규모 : 유형별
시장 개요
웨어러블
모바일 기반 애플리케이션
센서
기타
디지털 바이오마커 시장 규모 : 임상 실천별
시장 개요
진단 디지털 바이오마커
모니터링 디지털 바이오마커
예측 및 예지 디지털 바이오마커
기타
디지털 바이오마커 시장 규모 : 치료 영역별
시장 개요
심혈관 및 대사질환(CVMD)
호흡기 질환
정신질환
수면 및 운동장해
신경질환
근골격계 장애
기타
디지털 바이오마커 시장 규모 : 최종사용자별
시장 개요
헬스케어 기업
의료 제공자
지불자
기타
디지털 바이오마커 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2022-2024년)
주요 기업 개요
BioSensics(United States)
AliveCor(United States)
BACtrack(United States)
Eyenuk(United States)
Quibim(Spain)
Biofourmis(United States)
Fitbit(United States)
Evidation Health(United States)
Empatica(United States)
Philips Healthcare(Netherlands)
Medtronic(Ireland)
Akili Interactive(United States)
Apple Inc.(United States)
Biotricity(United States)
Tempus(United States)
Pear Therapeutics(United States)
BioBeats(United Kingdom)
Oura Health(Finland)
ActiGraph(United States)
Koneksa(United States)
결론과 제안
LSH
영문 목차
영문목차
Global Digital Biomarkers Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 5.02 billion in 2024 to USD 38.05 billion by 2032, growing at a CAGR of 28.8% during the forecast period (2025-2032).
The digital biomarkers market is experiencing robust growth, driven by rising demand for telecare services and remote patient monitoring, alongside rapid advancements in healthcare technology and increased healthcare expenditure. Key factors propelling this market include growing investments in decentralized clinical trials, expanding therapeutic applications, and the surge in wearable devices amid widespread smartphone usage. Innovative technologies capable of detecting vital indicators such as breathing, voice, heat, and eye movements are enabling real-time monitoring of complex diseases. Notably, vocal digital biomarkers present significant growth opportunities. Initiatives like the CoLive Voice by the Luxembourg Institute of Health highlight the potential for remote risk assessment and disease management. With an increasing number of consumers utilizing smartwatches and fitness trackers, the market is poised for continued expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Biomarkers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Digital Biomarkers Market Segments Analysis
Global Digital Biomarkers Market is segmented by Type, Clinical Practice, Therapeutic Area, End Users and region. Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors and Others. Based on Clinical Practice, the market is segmented into Diagnostic digital biomarkers, Monitoring digital biomarkers, Predictive and Prognostic digital biomarkers and Others. Based on Therapeutic Area, the market is segmented into Cardiovascular and metabolic disorders (CVMD), Respiratory disorders, Psychiatric disorders, Sleep & Movement Disease, Neurological disorders, Musculoskeletal disorders and Others. Based on End Users, the market is segmented into Healthcare companies, Healthcare Providers, Payers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Digital Biomarkers Market
The rise in the prevalence of diabetes, hypertension, and cardiovascular diseases is driving the demand for digital biomarkers. These advanced health indicators provide essential insights that enable healthcare systems to respond promptly and maintain continuous monitoring of chronic conditions. By facilitating optimal management practices, digital biomarkers empower patients to maintain their health for extended periods and minimize hospital visits. This proactive approach not only enhances patients' quality of life but also helps reduce overall healthcare costs. Consequently, the increasing focus on managing chronic illnesses is significantly fueling the global market for digital biomarkers, highlighting their importance in modern healthcare.
Restraints in the Global Digital Biomarkers Market
While digital biomarkers show significant potential, a major challenge lies in their lack of clinical validation, which is essential for their widespread acceptance among medical professionals. Due to insufficient rigorous research to establish their effectiveness in real-world applications, concerns regarding their accuracy and reliability are prevalent. This gap in validation hinders the broader acceptance and integration of digital biomarkers into standard treatment protocols, as healthcare providers prefer to utilize evidence-based tools that have proven efficacy. Consequently, the limited clinical validation of these biomarkers may impede their ability to gain traction in routine medical practice, posing a significant restraint in the global digital biomarkers market.
Market Trends of the Global Digital Biomarkers Market
The Global Digital Biomarkers market is witnessing a significant trend towards the integration of artificial intelligence (AI), which enhances the capability of wearables and health applications to generate data. By employing advanced AI algorithms to analyze and interpret this data, healthcare providers can uncover patterns and insights that might not be readily apparent, leading to more proactive and individualized healthcare approaches. This trend is pivotal in improving illness management and optimizing patient outcomes, as it amplifies the predictive power of digital biomarkers. Consequently, the market is positioned for robust growth, driven by the increasing reliance on technology for personal health monitoring and disease management.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis
Global Digital Biomarkers Market Size by Type & CAGR (2025-2032)
Market Overview
Wearable
Mobile based Applications
Sensors
Others
Global Digital Biomarkers Market Size by Clinical Practice & CAGR (2025-2032)
Market Overview
Diagnostic digital biomarkers
Monitoring digital biomarkers
Predictive and Prognostic digital biomarkers
Others
Global Digital Biomarkers Market Size by Therapeutic Area & CAGR (2025-2032)
Market Overview
Cardiovascular and metabolic disorders (CVMD)
Respiratory disorders
Psychiatric disorders
Sleep & Movement Disease
Neurological disorders
Musculoskeletal disorders
Others
Global Digital Biomarkers Market Size by End Users & CAGR (2025-2032)
Market Overview
Healthcare companies
Healthcare Providers
Payers
Others
Global Digital Biomarkers Market Size & CAGR (2025-2032)
North America (Type, Clinical Practice, Therapeutic Area, End Users)
US
Canada
Europe (Type, Clinical Practice, Therapeutic Area, End Users)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Clinical Practice, Therapeutic Area, End Users)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Clinical Practice, Therapeutic Area, End Users)
Brazil
Rest of Latin America
Middle East & Africa (Type, Clinical Practice, Therapeutic Area, End Users)
